Nanotoxicology of Dendrimers in the Mammalian Heart: ex vivo and in vivo Administration of G6 PAMAM Nanoparticles Impairs Recovery of Cardiac Function Following Ischemia-Reperfusion Injury

Fawzi Babiker,1 Ibrahim F Benter,2 Saghir Akhtar3 1Department of Physiology, Faculty of Medicine, Health Science Center, Kuwait University, Kuwait City, Kuwait; 2Faculty of Medicine, Eastern Mediterranean University, Famagusta, North Cyprus, Republic of Cyprus; 3College of Medicine, QU Health, Qatar...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Babiker F, Benter IF, Akhtar S
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	pamam postconditioning diabetes ischemia/reperfusion Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/0b2b92b9241943789716085503ff58ca
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:0b2b92b9241943789716085503ff58ca
record_format	dspace
spelling	oai:doaj.org-article:0b2b92b9241943789716085503ff58ca2021-12-02T10:06:28ZNanotoxicology of Dendrimers in the Mammalian Heart: ex vivo and in vivo Administration of G6 PAMAM Nanoparticles Impairs Recovery of Cardiac Function Following Ischemia-Reperfusion Injury1178-2013https://doaj.org/article/0b2b92b9241943789716085503ff58ca2020-06-01T00:00:00Zhttps://www.dovepress.com/nanotoxicology-of-dendrimers-in-the-mammalian-heart-ex-vivo-and-in-viv-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Fawzi Babiker,1 Ibrahim F Benter,2 Saghir Akhtar3 1Department of Physiology, Faculty of Medicine, Health Science Center, Kuwait University, Kuwait City, Kuwait; 2Faculty of Medicine, Eastern Mediterranean University, Famagusta, North Cyprus, Republic of Cyprus; 3College of Medicine, QU Health, Qatar University, Doha, QatarCorrespondence: Fawzi BabikerDepartment of Physiology, Faculty of Medicine, Health Science Center, Kuwait University, PO Box 24923, Safat 13110, Kuwait, Tel +965 24636360Fax +965 25338937Email Fawzi.b@hsc.edu.kwSaghir AkhtarCollege of Medicine, QU Health, Qatar University, PO Box 2713, Doha, QatarTel +974-4403 7865Email s.akhtar@qu.edu.qaAim: The effects of polyamidoamine (PAMAM) dendrimers on the mammalian heart are not completely understood. In this study, we have investigated the effects of a sixth-generation cationic dendrimer (G6 PAMAM) on cardiac function in control and diabetic rat hearts following ischemia-reperfusion (I/R) injury.Methods: Isolated hearts from healthy non-diabetic (Ctr) male Wistar rats were subjected to ischemia and reperfusion (I/R). LV contractility and hemodynamics data were computed digitally whereas cardiac damage following I/R injury was assessed by measuring cardiac enzymes. For ex vivo acute exposure experiments, G6 PAMAM was administered during the first 10 mins of reperfusion in Ctr animals. In chronic in vivo studies, nondiabetic rats (Ctr) received either vehicle or daily i.p. injections of G6 PAMAM (40 mg/kg) for 4 weeks. Diabetic (D) animals received either vehicle or daily i.p. injections of G6 PAMAM (10, 20 or 40 mg/kg) for 4 weeks. The impact of G6 PAMAM on pacing-postconditioning (PPC) was also studied in Ctr and D rats.Results: In ex vivo studies, acute administration of G6 PAMAM to isolated Ctr hearts during reperfusion dose-dependently impaired recovery of cardiac hemodynamics and vascular dynamics parameters following I/R injury. Chronic daily i.p. injections of G6 PAMAM significantly (P< 0.01) impaired recovery of cardiac function following I/R injury in nondiabetic animals but this was not generally observed in diabetic animals except for CF which was impaired by about 50%. G6 PAMAM treatment completely blocked the protective effects of PPC in the Ctr animals.Conclusion: Acute ex vivo or chronic in vivo treatment with naked G6 PAMAM dendrimer can significantly compromise recovery of non-diabetic hearts from I/R injury and can further negate the beneficial effects of PPC. Our findings are therefore extremely important in the nanotoxicological evaluation of G6 PAMAM dendrimers for potential clinical applications in physiological and pathological settings.Keywords: PAMAM, postconditioning, diabetes, ischemia, reperfusionBabiker FBenter IFAkhtar SDove Medical Pressarticlepamampostconditioningdiabetesischemia/reperfusionMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 15, Pp 4393-4405 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	pamam postconditioning diabetes ischemia/reperfusion Medicine (General) R5-920
spellingShingle	pamam postconditioning diabetes ischemia/reperfusion Medicine (General) R5-920 Babiker F Benter IF Akhtar S Nanotoxicology of Dendrimers in the Mammalian Heart: ex vivo and in vivo Administration of G6 PAMAM Nanoparticles Impairs Recovery of Cardiac Function Following Ischemia-Reperfusion Injury
description	Fawzi Babiker,1 Ibrahim F Benter,2 Saghir Akhtar3 1Department of Physiology, Faculty of Medicine, Health Science Center, Kuwait University, Kuwait City, Kuwait; 2Faculty of Medicine, Eastern Mediterranean University, Famagusta, North Cyprus, Republic of Cyprus; 3College of Medicine, QU Health, Qatar University, Doha, QatarCorrespondence: Fawzi BabikerDepartment of Physiology, Faculty of Medicine, Health Science Center, Kuwait University, PO Box 24923, Safat 13110, Kuwait, Tel +965 24636360Fax +965 25338937Email Fawzi.b@hsc.edu.kwSaghir AkhtarCollege of Medicine, QU Health, Qatar University, PO Box 2713, Doha, QatarTel +974-4403 7865Email s.akhtar@qu.edu.qaAim: The effects of polyamidoamine (PAMAM) dendrimers on the mammalian heart are not completely understood. In this study, we have investigated the effects of a sixth-generation cationic dendrimer (G6 PAMAM) on cardiac function in control and diabetic rat hearts following ischemia-reperfusion (I/R) injury.Methods: Isolated hearts from healthy non-diabetic (Ctr) male Wistar rats were subjected to ischemia and reperfusion (I/R). LV contractility and hemodynamics data were computed digitally whereas cardiac damage following I/R injury was assessed by measuring cardiac enzymes. For ex vivo acute exposure experiments, G6 PAMAM was administered during the first 10 mins of reperfusion in Ctr animals. In chronic in vivo studies, nondiabetic rats (Ctr) received either vehicle or daily i.p. injections of G6 PAMAM (40 mg/kg) for 4 weeks. Diabetic (D) animals received either vehicle or daily i.p. injections of G6 PAMAM (10, 20 or 40 mg/kg) for 4 weeks. The impact of G6 PAMAM on pacing-postconditioning (PPC) was also studied in Ctr and D rats.Results: In ex vivo studies, acute administration of G6 PAMAM to isolated Ctr hearts during reperfusion dose-dependently impaired recovery of cardiac hemodynamics and vascular dynamics parameters following I/R injury. Chronic daily i.p. injections of G6 PAMAM significantly (P< 0.01) impaired recovery of cardiac function following I/R injury in nondiabetic animals but this was not generally observed in diabetic animals except for CF which was impaired by about 50%. G6 PAMAM treatment completely blocked the protective effects of PPC in the Ctr animals.Conclusion: Acute ex vivo or chronic in vivo treatment with naked G6 PAMAM dendrimer can significantly compromise recovery of non-diabetic hearts from I/R injury and can further negate the beneficial effects of PPC. Our findings are therefore extremely important in the nanotoxicological evaluation of G6 PAMAM dendrimers for potential clinical applications in physiological and pathological settings.Keywords: PAMAM, postconditioning, diabetes, ischemia, reperfusion
format	article
author	Babiker F Benter IF Akhtar S
author_facet	Babiker F Benter IF Akhtar S
author_sort	Babiker F
title	Nanotoxicology of Dendrimers in the Mammalian Heart: ex vivo and in vivo Administration of G6 PAMAM Nanoparticles Impairs Recovery of Cardiac Function Following Ischemia-Reperfusion Injury
title_short	Nanotoxicology of Dendrimers in the Mammalian Heart: ex vivo and in vivo Administration of G6 PAMAM Nanoparticles Impairs Recovery of Cardiac Function Following Ischemia-Reperfusion Injury
title_full	Nanotoxicology of Dendrimers in the Mammalian Heart: ex vivo and in vivo Administration of G6 PAMAM Nanoparticles Impairs Recovery of Cardiac Function Following Ischemia-Reperfusion Injury
title_fullStr	Nanotoxicology of Dendrimers in the Mammalian Heart: ex vivo and in vivo Administration of G6 PAMAM Nanoparticles Impairs Recovery of Cardiac Function Following Ischemia-Reperfusion Injury
title_full_unstemmed	Nanotoxicology of Dendrimers in the Mammalian Heart: ex vivo and in vivo Administration of G6 PAMAM Nanoparticles Impairs Recovery of Cardiac Function Following Ischemia-Reperfusion Injury
title_sort	nanotoxicology of dendrimers in the mammalian heart: ex vivo and in vivo administration of g6 pamam nanoparticles impairs recovery of cardiac function following ischemia-reperfusion injury
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/0b2b92b9241943789716085503ff58ca
work_keys_str_mv	AT babikerf nanotoxicologyofdendrimersinthemammalianheartexvivoandinvivoadministrationofg6pamamnanoparticlesimpairsrecoveryofcardiacfunctionfollowingischemiareperfusioninjury AT benterif nanotoxicologyofdendrimersinthemammalianheartexvivoandinvivoadministrationofg6pamamnanoparticlesimpairsrecoveryofcardiacfunctionfollowingischemiareperfusioninjury AT akhtars nanotoxicologyofdendrimersinthemammalianheartexvivoandinvivoadministrationofg6pamamnanoparticlesimpairsrecoveryofcardiacfunctionfollowingischemiareperfusioninjury
_version_	1718397633205108736

Nanotoxicology of Dendrimers in the Mammalian Heart: ex vivo and in vivo Administration of G6 PAMAM Nanoparticles Impairs Recovery of Cardiac Function Following Ischemia-Reperfusion Injury

Ejemplares similares